Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases

Toll-like receptor 2 and -4 are involved in the pathogenesis of the Guillain-Barre syndrome

First author:YAMEI DU

Corresponding author:GUOJUN ZHANG

Toll-like receptor 2 Toll-like receptor -4 Guillai

essential_information

  • Person in charge:YAMEI DU
  • Data Sources: OTHERS
  • Number of papers:OTHERS20190349
  • Published time:2015-08-01

2015-08-01

Published articles

Journal:Molecular Medicine Reports

Publication type: Original Article

IF(IF): 2.952

PMID: 25954926 Link To Pubmed Full text Download

Background And Purpose

Method

Therefore, the mRNA of TLR2, TLR4, myeloid differentiation factor (MyD)88 and nuclear factor (NF)-κB of peripheral blood mononuclear cells (PBMCs) in patients with GBS and healthy controls was assessed. To confirm the function of TLR2 and TLR4 in the pathogenesis of GBS, PBMCs derived from patients with GBS and healthy controls were cultured with various TLR agonists. The levels of tumor necrosis factor (TNF)-α and interleukin (IL)-1β were measured in the culture supernatant and fasting serum was obtained for the detection of anti-ganglioside antibodies.

Conclusion

The results of the present study demonstrated that TLR2 and TLR4 are involved in the pathogenesis of GBS and that they and their associated signaling pathways may be targets for the treatment of GBS.

Main results

The results revealed that the mRNA levels of TLR2, TLR4, MyD88 and NF-κB were significantly increased in patients with GBS compared with those in healthy controls (P=0.003, 0.017, 0.032 and 0.015, respectively). PBMCs from patients with GBS secreted higher levels of TNF-α and IL-1β than those from control subjects. The positive rate of immunoglobulin (Ig)G and IgM anti-ganglioside antibodies in patients with severe GBS was 42.86%, which was markedly higher than rates found in patients with mild GBS (9.09 and 18.18%, respectively).